New and Improved Service

Posted:
26
August 2004

Claire Tucker, Head of Sales and Marketing

Richmond Pharmacology's (RPL's) highly successful business team has recently undergone a re-organisation to enhance the outstanding service we provide to our valued clients.Claire Tucker, Head of Sales and Marketing, commented:‘Our improved structure includes dedicated business Account Managers, specifically allocated to a particular client and able to guide them through the initial stages of introduction and study specific contract negotiation. These Account Managers continue to be at hand throughout as an additional point of contact until the study has reached its completion. As usual, our proficient Clinical Project Managers will co-ordinate the smooth day-to-day running of the study and will continue to work on a one to one basis with client teams. I am delighted with the new structure and the impact this is already having on our clients.’This framework has been introduced to ensure even better communication from initial contact through to close out, maintaining RPL's supportive and personal approach.Providing additional support for Phase II is our dedicated Phase II Department, see more on our patient studies page.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more